Krzysztof Walczak

Prof. Krzysztof Walczak

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MTMateusz D. Tomczyk
Mateusz D. Tomczyk
KWKrzysztof Walczak
Krzysztof Walczak

1 October 2004 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KWKrzysztof Walczak
Krzysztof Walczak
AGAndrzej Gondela
Andrzej Gondela
JSJerzy Suwiński
Jerzy Suwiński

24 April 2014 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
KEKarol Erfurt
Karol Erfurt
Ilona WandzikIlona Wandzik
Ilona Wandzik
KWKrzysztof Walczak
Krzysztof Walczak
Karolina MatuszekKarolina Matuszek
Karolina Matuszek
Anna ChrobokAnna Chrobok
Anna Chrobok
The synthesis and characterisation of new hydrogen-bond-rich ionic liquids and studies of their catalytic performance in Diels–Alder reactions are described. D-Glucose and chloroalcohols were used as the raw materials and as the sources of hydroxyl groups for the synthesis of ionic-liquid cations, whereas weakly coordinating bis(trifluoromethylsulfonyl)imide was used as the anion. The new ionic liquids were analysed by 1H and 13C NMR spectroscopy and by ESI-MS experiments, which confirmed their structures. In addition, the thermal data of the studied ionic liquids measured by differential scanning calorimetry and thermogravimetric analysis showed that these compounds tend to form a glass at temperatures in the range of −29 °C to −16 °C and are thermally stable from ambient temperature to at least 430 °C, most likely because of the presence of bis(trifluoromethylsulfonyl)imide anions. The performance of the ionic liquids in the model reaction of cyclopentadiene with diethyl maleate or methyl acrylate was investigated. The studied ionic liquids showed high activity even when present in catalytic amounts (4 mol% with respect to the dienophile). An increase in the number of hydroxyl groups present in the ionic liquid structure resulted in higher reaction rates.

1 October 2011 in Biomaterials
Verified
Journal Article
Closed access
SBSlawomir Boncel
Slawomir Boncel
KMKarin H. Müller
Karin H. Müller
JSJeremy N. Skepper
Jeremy N. Skepper
KWKrzysztof Walczak
Krzysztof Walczak
KKKrzysztof K.K. Koziol
Krzysztof K.K. Koziol

1 July 2011 in Materials Letters
Verified
Journal Article
Closed access
SBSlawomir Boncel
Slawomir Boncel
KKKrzysztof K.K. Koziol
Krzysztof K.K. Koziol
KWKrzysztof Walczak
Krzysztof Walczak
AWAlan H. Windle
Alan H. Windle
MSMilo S.P. Shaffer
Milo S.P. Shaffer

1 December 2019 in European Journal of Pharmacology
Verified
Journal Article
Open access
GPGabriela Pastuch-Gawolek
Gabriela Pastuch-Gawolek
DGDanuta M. Gillner
Danuta M. Gillner
EKEwelina Krol
Ewelina Krol
KWKrzysztof Walczak
Krzysztof Walczak
Ilona WandzikIlona Wandzik
Ilona Wandzik
Nucleos(t)ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum activity towards multiple life-threatening RNA and DNA viruses. We also present a discussion about nucleoside antimetabolites-approved antineoplastic agents-that have recently been shown to have antiviral and/or antibacterial activity. The approved drugs and drug combinations, as well as recently identified candidates for investigation and/or experimentation, are discussed. Several examples of repurposed drugs that have already been approved for use are presented. This strategy can be crucial for the first-line treatment of acute infections or coinfections and for the management of drug-resistant strains.